+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Captopril"

ACE Inhibitors Global Market Report 2024 - Product Thumbnail Image

ACE Inhibitors Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
Global and Chinese Captopril Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Captopril Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 144 Pages
  • China, Global
From
From
Hypertension Drugs Markets in China - Product Thumbnail Image

Hypertension Drugs Markets in China

  • Report
  • November 2023
  • 215 Pages
  • China
From
Hypertension Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Hypertension Drugs Industry Forecasts - China Focus

  • Report
  • November 2023
  • 109 Pages
  • China
From
  • 12 Results (Page 1 of 1)
Loading Indicator

Captopril is a drug used to treat cardiovascular diseases, such as hypertension, congestive heart failure, and myocardial infarction. It is a prodrug, meaning it is converted into its active form, captoprilat, in the body. Captopril is an angiotensin-converting enzyme (ACE) inhibitor, which works by blocking the production of angiotensin II, a hormone that causes blood vessels to constrict. This helps to reduce blood pressure and improve blood flow. Captopril is one of the most widely used cardiovascular drugs, and is available in both generic and branded forms. It is available in tablet, capsule, and liquid forms, and is usually taken once or twice daily. It is generally well-tolerated, but can cause side effects such as dizziness, headache, and nausea. The captopril market is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. Show Less Read more